Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra.
The effects of seganserin, a specific 5HT2 antagonist, on human sleep were assessed in two experiments and compared to the effects of temazepam and sleep deprivation. During daytime recovery sleep after sleep deprivation, seganserin did not significantly enhance visually scored slow wave sleep (SWS, stages 3 + 4) or the EEG power density in the delta frequencies. Under these conditions temazepam reduced the power density in the delta and theta frequencies. During nighttime sleep after a nap in the evening, seganserin caused an increase in SWS, a reduction in intermittent wakefulness, and an enhancement of the power density in the delta and theta frequencies during non-rapid eye movement (NREM) sleep. Temazepam induced a reduction in the power density in the delta and theta frequencies. It is concluded that the 5HT2 antagonist, seganserin, can induce SWS. However, since the spectral results showed that the changes in the sleep EEG were not identical to those induced by sleep deprivation it seems premature to conclude that 5HT2 receptors are primarily involved in NREM sleep regulation.
Dijk
D J
DJ
Department of Biological Psychiatry, University of Groningen, The Netherlands.
Beersma
D G
DG
Daan
S
S
van den Hoofdakker
R H
RH
D000328:Adult; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D004569:Electroencephalography; D004576:Electromyography; D004585:Electrooculography; D006801:Humans; D008297:Male; D010880:Piperidines / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D012892:Sleep Deprivation / Q000502:physiology; D012894:Sleep Stages / Q000187:drug effects*; D012895:Sleep, REM / Q000187:drug effects; D013693:Temazepam / Q000494:pharmacology*
D014151:Anti-Anxiety Agents; D010880:Piperidines; D012702:Serotonin Antagonists; C046301:seganserin; D013693:Temazepam